Results 31 to 40 of about 4,318,091 (252)

Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. [PDF]

open access: yes, 2010
TGR5, the G protein-coupled bile acid receptor 1 (GPBAR1), has been linked to inflammatory pathways as well as bile homeostasis, and could therefore be involved in primary sclerosing cholangitis (PSC) a chronic inflammatory bile duct disease. We aimed to
Bergquist Annika   +186 more
core   +4 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Drug therapy of primary biliary diseases: classical and modern strategies [PDF]

open access: yes, 2013
Definition: Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are both cholestatic liver diseases. A common feature of these disorders is the accumulation of bile acids in the liver and blood, presumably because of decreased ...
Leuschner, Ulrich, Schlichting, Julia
core   +1 more source

Primary sclerosing cholangitis: a pre-malignant condition [PDF]

open access: yes, 2017
Primary sclerosing cholangitis (PSC) is a chronic, progressive, cholestatic liver disease with no known cure. It is a serious condition, and diagnosis comes with an increased risk of developing cancer of the gallbladder, bile ducts or liver.
Gerri Mortimore, Mortimore, Gerri
core   +1 more source

Primary Sclerosing Cholangitis [PDF]

open access: yesRadiology, 1970
Summary The literature on the subject of sclerosing cholangitis is reviewed. The value of conserving the gall bladder, of operative cholangiography and of the administration of steroids in the management of these patients is emphasized.
openaire   +3 more sources

Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies

open access: yesAnnals of Hepatology, 2020
Primary biliary cholangitis and primary sclerosing cholangitis are rare diseases affecting the bile ducts and the liver. The limited knowledge of their pathogenesis leads to limited therapeutic options.
Alessio Gerussi   +5 more
doaj   +1 more source

Aberrant hepatic trafficking of gut-derived T cells is not specific to primary sclerosing cholangitis [PDF]

open access: yes, 2022
Background and Aims The “gut homing” hypothesis suggests the pathogenesis of primary sclerosing cholangitis (PSC) is driven by aberrant hepatic expression of gut adhesion molecules and subsequent recruitment of gut‐derived T cells to the liver. However,
Huang, Zhenlin   +18 more
core   +1 more source

Characteristic Findings of Primary Sclerosing Cholangitis on Endoscopic Retrograde Cholangiography: Which is the Most Common Finding? [PDF]

open access: yes, 2011
Background Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease and one of the most common indications for liver transplantation in adults.
Aida Rasoulzadeh   +13 more
core   +1 more source

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Successful low-dose azathioprine for myasthenia gravis despite hepatopathy from primary sclerosing cholangitis: a case report

open access: yesJournal of Medical Case Reports, 2010
Introduction Although myasthenia gravis is frequently associated with other disorders, it has not been reported together with primary sclerosing cholangitis, complicating the administration of liver-toxic immunosuppressive therapy. Case presentation A 73-
Höflich Sonja, Finsterer Josef
doaj   +1 more source

Home - About - Disclaimer - Privacy